Early human B cell response to Ebola virus in four U.S. survivors of infection
WILLIAMSON, ET AL. 2019. J VIROL, DOI:10.1128/JVI.01439-18
RESOURCES
Where research scientists come to find up to date resources on antibody discovery against challenging membrane protein targets.
Menu
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes
FOX, ET AL. 2019. SCI IMMUNOL, 4(32): EAAV5062
Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
LONG, ET AL. 2019. PNAS DOI: 10.1073/PNAS.1815432116.
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth
CHUKWUMA, ET AL. 2018. PLOS ONE 13(12), E0209437.
Broadly neutralizing antibody mediated clearance of human hepatitis C virus infection
KINCHEN, ET AL. 2018. CELL HOST MICROBE 24:717-730.
In vivo delivery of synthetic human DNA-encoded monoclonal antibodies protect against ebolavirus infection in a mouse model
PATEL, ET AL. 2018. CELL REPORTS 25:1982-1993.
CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry
VAN HOUT, ET AL. BIOCHEM PHARMACOL 158:402-412.
Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection
SAPHIRE, ET AL. 2018. CELL 174(4):938-952
Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the ebolavirus glycoprotein
GILCHUK, ET AL. 2018. IMMUNITY 49(2):363-374.
